Hardman & Co Investor Forum Research on Shield Therapeutics (STX): Proactive cash management to cashflow-breakeven
Shield is a commercial-stage pharma company delivering specialty products that address the needs of patients with iron deficiency (ID). Since its...
130 Views
Hardman & Co Investor Forum Research on Custodian Property Income REIT (CREI): Good momentum
The structure and investment remit of the real estate investment trust (REIT) have been proven to be resilient and position it strongly for the...
147 Views
Duke Capital (DUKE): Taking Duke Capital to the next level
In our April 2024 initiation, we highlighted that DUKE, by optimising the best of equity and debt, aimed to achieve equity-type returns with debt...
133 Views
NB Private Equity Partners - CM Day: 6 November Fireworks
The key takeaways from NBPE’s 6 November CM day, in our view, were i) positive market indications, including exits and an increase in the...
87 Views
The Hardman & Co Monthly: November 2024
Feature article: “ROOM” (Running Out of Money) risk, How managing liquidity risk can sustain corporate value and maintain shareholder confidence
121 Views